The Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST), and other rare diseases, through patient-powered research, education and empowerment, and global advocacy efforts.
Other Programs Supported by The Life Raft Group:
Real World Evidence In Action
Traditional models for cancer research have resulted in many breakthrough treatments for patients, but it is not enough. The LRGβs approach to GIST research through real world evidence, relies on timely, accurate data from the patientβs perspective, with patient survival as the primary objective.
RECENT LRG DATA
Update your Patient Registry Info.
Join The Life Raft Group.
Current GIST Clinical Trials.
Search the GIST Specialist Database.
HELP US SAVE LIVES
The Life Raft Group is a community and it is up to all of us to make a difference. There are many ways to help. We always need patient tissue and data in our GIST patient registry. Volunteering your time or making a monetary donation also helps us drive research forward and save lives.
News
The Life Raft Group Celebrates 15 Years of Accomplishments
The Life Raft Group became a formal non-profit on June 10, 2002. Begun as a grass roots effort by a group [...]
This is Not the End – A Survivor’s Story
A story about a cancer survivor recently appeared in the Washington Post: βThis is not the end; Using immunotherapy and a [...]
GIST Awareness Day (GAD) 2017 – Be a #Hero4Cancer
The LRG is gearing up for our third annual GIST Awareness Day (GAD) on July 13, 2017 with our theme, Be [...]
Latest Issue of the GIST and Sarcoma Journal is Now Available Online
The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a [...]
National LeioMyoSarcoma Foundation and the Life Raft Group Announce Collaboration
The Life Raft Group is pleased to announce a new collaboration to provide access to our valuable resource tool, [...]
New Data Indicates Imatinib Boosts Long-Term Survival for Some GIST Patients
A significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease [...]
The Life Raft Group Patient Registry in Review 2016
The Life Raft Group Patient Registry has over 15 years of self-reported and clinical data encompassing 35 years of patient [...]
Collaboration Lays the Groundwork for Breakthroughs in GIST
This article originally appeared in the January 30th edition of Cure Today. Less than two decades ago, Gleevec (imatinib) drastically changed [...]


























